Related Experiment Video
Updated: Apr 6, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Psoriasis: The Poster Child for Bench-to-bedside Translational Medicine
Lotus Mallbris1, Brian J Nickoloff1
1Eli Lilly and Company, Indianapolis, Indiana.
Insights
Psoriasis research exemplifies successful translational medicine, improving patient well-being beyond skin lesions. This cycle of collaboration highlights dermatology
Area of Science:
- Dermatology and immunology research
- Translational medicine in clinical practice
Background:
- The skin, as the largest organ, offers unique opportunities for studying immune responses.
- Translational medicine involves a bidirectional exchange between basic research and clinical practice.
- Patient-reported outcomes and well-being are increasingly important in dermatological studies.
Purpose of the Study:
- To highlight the successful translational cycle in psoriasis research.
- To showcase the collaborative efforts between patients, clinicians, and industry.
- To underscore the potential of dermatology research in advancing translational medicine.
Main Methods:
- Review of interactions within psoriasis research.
- Analysis of bench-to-bedside and bedside-to-bench approaches.
- Focus on patient-centric outcomes and well-being.
Main Results:
- Psoriasis research serves as a model for personalized cancer therapy.
- Successful collaboration between psoriasis patients, dermatologists, immunologists, and the pharmaceutical industry.
- Significant advancements in understanding and treating psoriasis.
Conclusions:
- Psoriasis research demonstrates the power of translational medicine in dermatology.
- Lessons learned from psoriasis studies indicate a promising future for translational research.
- The collaborative model can enhance patient lives and well-being.
Abstract:
As the largest and most visible organ, the skin provides opportunities to investigate immune responses in clinical studies offering insights that extend beyond our protective coat. The interplay between bench-to-bedside approaches are complemented by bedside-to-bench exchanges epitomizing translational medicine. Conversations beyond improvement in skin lesions that include the impact on patients' lives and well-being are also becoming more frequent. Just as advances in the realm of cutaneous oncology earned malignant melanoma the title of poster child for personalized cancer therapy, new advances involving psoriasis are pointing to this moniker in dermatology once again. In this commentary, the successful cycle of interactions between psoriasis patients, dermatologists, immunologists, and the pharmaceutical industry are highlighted. Lessons learned from psoriasis-based studies indicate a bright future for translational medicine based in dermatology research labs and clinics.
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research

